Avanos Medical (AVNS) Capital Expenditures (2013 - 2026)

Avanos Medical's Capital Expenditures history runs 14 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 35.82% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at -$800000.0 (down 109.76% YoY), while the FY2025 annual figure was $1.6 million, down 71.43% from the prior year.
• Capital Expenditures came in at $4.3 million for Q1 2026 at Avanos Medical, up from -$23.1 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $11.0 million in Q2 2025 to a low of -$23.1 million in Q4 2025.
• A 5-year average of $2.0 million and a median of $4.1 million in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 156.19% in 2023 and sank 225.42% in 2024, its largest moves.
• Avanos Medical's Capital Expenditures stood at -$10.5 million in 2022, then surged by 156.19% to $5.9 million in 2023, then tumbled by 225.42% to -$7.4 million in 2024, then slumped by 212.16% to -$23.1 million in 2025, then soared by 118.61% to $4.3 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $4.3 million, -$23.1 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison